194 related articles for article (PubMed ID: 1966798)
1. Structure of the lysine-fibrin binding subsite of human plasminogen kringle 4.
Mulichak AM; Tulinsky A
Blood Coagul Fibrinolysis; 1990 Dec; 1(6):673-9. PubMed ID: 1966798
[TBL] [Abstract][Full Text] [Related]
2. Structure and binding determinants of the recombinant kringle-2 domain of human plasminogen to an internal peptide from a group A Streptococcal surface protein.
Rios-Steiner JL; Schenone M; Mochalkin I; Tulinsky A; Castellino FJ
J Mol Biol; 2001 May; 308(4):705-19. PubMed ID: 11350170
[TBL] [Abstract][Full Text] [Related]
3. Ligand preferences of kringle 2 and homologous domains of human plasminogen: canvassing weak, intermediate, and high-affinity binding sites by 1H-NMR.
Marti DN; Hu CK; An SS; von Haller P; Schaller J; Llinás M
Biochemistry; 1997 Sep; 36(39):11591-604. PubMed ID: 9305949
[TBL] [Abstract][Full Text] [Related]
4. Lysine/fibrin binding sites of kringles modeled after the structure of kringle 1 of prothrombin.
Tulinsky A; Park CH; Mao B; Llinás M
Proteins; 1988; 3(2):85-96. PubMed ID: 3135547
[TBL] [Abstract][Full Text] [Related]
5. Structure and ligand binding determinants of the recombinant kringle 5 domain of human plasminogen.
Chang Y; Mochalkin I; McCance SG; Cheng B; Tulinsky A; Castellino FJ
Biochemistry; 1998 Mar; 37(10):3258-71. PubMed ID: 9521645
[TBL] [Abstract][Full Text] [Related]
6. Crystal structures of apolipoprotein(a) kringle IV37 free and complexed with 6-aminohexanoic acid and with p-aminomethylbenzoic acid: existence of novel and expected binding modes.
Mikol V; LoGrasso PV; Boettcher BR
J Mol Biol; 1996 Mar; 256(4):751-61. PubMed ID: 8642595
[TBL] [Abstract][Full Text] [Related]
7. Solution structure and functional characterization of human plasminogen kringle 5.
Battistel MD; Grishaev A; An SS; Castellino FJ; Llinás M
Biochemistry; 2009 Nov; 48(43):10208-19. PubMed ID: 19821587
[TBL] [Abstract][Full Text] [Related]
8. Recombinant kringle IV-10 modules of human apolipoprotein(a): structure, ligand binding modes, and biological relevance.
Mochalkin I; Cheng B; Klezovitch O; Scanu AM; Tulinsky A
Biochemistry; 1999 Feb; 38(7):1990-8. PubMed ID: 10026282
[TBL] [Abstract][Full Text] [Related]
9. Structural/functional characterization of the alpha 2-plasmin inhibitor C-terminal peptide.
Frank PS; Douglas JT; Locher M; Llinás M; Schaller J
Biochemistry; 2003 Feb; 42(4):1078-85. PubMed ID: 12549929
[TBL] [Abstract][Full Text] [Related]
10. A structural assessment of the apo[a] protein of human lipoprotein[a].
Guevara J; Knapp RD; Honda S; Northup SR; Morrisett JD
Proteins; 1992 Feb; 12(2):188-99. PubMed ID: 1318546
[TBL] [Abstract][Full Text] [Related]
11. Antiangiogenic kringles derived from human plasminogen and apolipoprotein(a) inhibit fibrinolysis through a mechanism that requires a functional lysine-binding site.
Ahn JH; Lee HJ; Lee EK; Yu HK; Lee TH; Yoon Y; Kim SJ; Kim JS
Biol Chem; 2011 Apr; 392(4):347-56. PubMed ID: 21194375
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein(a): structure-function relationship at the lysine-binding site and plasminogen activator cleavage site.
Anglés-Cano E; Rojas G
Biol Chem; 2002 Jan; 383(1):93-9. PubMed ID: 11928826
[TBL] [Abstract][Full Text] [Related]
13. Nuclear magnetic resonance (NMR) solution structure, dynamics, and binding properties of the kringle IV type 8 module of apolipoprotein(a).
Chitayat S; Kanelis V; Koschinsky ML; Smith SP
Biochemistry; 2007 Feb; 46(7):1732-42. PubMed ID: 17263558
[TBL] [Abstract][Full Text] [Related]
14. The construction and expression of chimeric urokinase-type plasminogen activator genes containing kringle domains of human plasminogen.
Boutaud A; Castellino FJ
Arch Biochem Biophys; 1993 Jun; 303(2):222-30. PubMed ID: 8512311
[TBL] [Abstract][Full Text] [Related]
15. Structures of the noncovalent complexes of human and bovine prothrombin fragment 2 with human PPACK-thrombin.
Arni RK; Padmanabhan K; Padmanabhan KP; Wu TP; Tulinsky A
Biochemistry; 1993 May; 32(18):4727-37. PubMed ID: 8387813
[TBL] [Abstract][Full Text] [Related]
16. The fibrin-binding site of human plasminogen. Arginines 32 and 34 are essential for fibrin affinity of the kringle 1 domain.
Váli Z; Patthy L
J Biol Chem; 1984 Nov; 259(22):13690-4. PubMed ID: 6094526
[TBL] [Abstract][Full Text] [Related]
17. Kringle-kringle interactions in multimer kringle structures.
Padmanabhan K; Wu TP; Ravichandran KG; Tulinsky A
Protein Sci; 1994 Jun; 3(6):898-910. PubMed ID: 8069221
[TBL] [Abstract][Full Text] [Related]
18. The X-ray crystallographic structure of the angiogenesis inhibitor angiostatin.
Abad MC; Arni RK; Grella DK; Castellino FJ; Tulinsky A; Geiger JH
J Mol Biol; 2002 May; 318(4):1009-17. PubMed ID: 12054798
[TBL] [Abstract][Full Text] [Related]
19. Crystal structures of the recombinant kringle 1 domain of human plasminogen in complexes with the ligands epsilon-aminocaproic acid and trans-4-(aminomethyl)cyclohexane-1-carboxylic Acid.
Mathews II; Vanderhoff-Hanaver P; Castellino FJ; Tulinsky A
Biochemistry; 1996 Feb; 35(8):2567-76. PubMed ID: 8611560
[TBL] [Abstract][Full Text] [Related]
20. Functional hierarchy of plasminogen kringles 1 and 4 in fibrinolysis and plasmin-induced cell detachment and apoptosis.
Ho-Tin-Noé B; Rojas G; Vranckx R; Lijnen HR; Anglés-Cano E
FEBS J; 2005 Jul; 272(13):3387-400. PubMed ID: 15978044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]